CNC (Centene Corp)
All Pro Portfolios with CNC
- Total Pro Portfolios with CNC:
- Accipiter Capital Management
- show more
- 1
All Do-It-Yourself Portfolios with CNC
- Total Do-It-Yourself Portfolios with CNC:
- robert nyilas Portfolio 1
- jpf
- Motley Fool 2007
- wwwman Portfolio 1
- SUPRATRADE2606071919
- Health Care Insurers Index
- bstreetman Portfolio 1
- 24WC II
- Fast Money's First 100 Days Trade
- show more
- 18
- SnowBawl Portfolio 1
- jpf prod
- SUPRATRADE OMEGATRUST IV
- SUPRATRADE 0606071437W
- Chris' Low Price and Fast Growth Stocks
- Joe Gregorek Portfolio 1
- SUPRATRADE 0909071931
- PART 1 JPMorgan 26th Annual Healthcare Conf 1/7/08..1st Day Reporting Companies..Nymph Take
- PART 1 JPMorgan 27th Annual Healthcare Conf 1/12/09..1st Day Reporting Companies..Nymph Take
- News For Selected Stock
- Related stories on theStreet.com
- videos related to etf's
- No videos found
- blogs related to etf's
- No blogs found
Why I Love This Stock |
|
By:barrons3 |
Date:11 12 08 |
Parmentier explained that Democrats will pump a ton of money into Medicaid. He told viewers to look at Molina Healthcare(MOH), Amerigroup(AGP), Centene(CNC), Affymetrix(AFFX) and UnitedHealth Group(UNH). |
|
Not yet rated
Rate now:
|
|
By:Pro |
Date:11 30 -1 |
Centene (CNC) was downgraded to Peer Perform rating at Bear Stearns as they believe the company has closed the valuation gap with the other pure plays in their sector. |
|
Not yet rated
Rate now:
|
|
By:Pro |
Date:11 30 -1 |
Centene (CNC) was upgraded to Hold rating from Under Perform at Jefferies. FY 2008 eps estimates rise to $1.60 from $1.55, and price target lifts to $19 from $18.60. |
|
Not yet rated
Rate now:
|
|
By:Pro |
Date:11 30 -1 |
Upgraded by Matrix Research from Buy to Strong Buy |
|
Not yet rated
Rate now:
|
|
By:Pro |
Date:11 30 -1 |
Downgraded by Jefferies & Co from Hold to Underperform |
|
Not yet rated
Rate now:
|
|
By:Sprucemoose2 |
Date:01 15 07 |
Buy this the week of 1/15. |
|
Not yet rated
Rate now:
|
|
By:Pro |
Date:11 30 -1 |
Downgraded by Goldman Sachs from Neutral to Sell |
|
Not yet rated
Rate now:
|
|
Why I Hate This Stock |
|
| Comments not available |